With heightened excitement centering on the recent announcement by Merck that its investigational antiviral therapy molnupiravir reduces the risk of hospitalization due to COVID-19, the…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.